2617.HK · TRANSTHERA-B
Hong Kong · RS rating 12 · As of 2026-10-14
| Price | 9.34 HKD |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 54 / 29 / 1 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 26 / 14 / 17 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +96.0% |
| Market cap (USD) | $541.2M |